Patents by Inventor William Francis Heath, Jr.

William Francis Heath, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6323178
    Abstract: The invention provides isolated nucleic acids, vectors, transformed host cells, analogs, functional fragments, and fusion proteins, related to beta-lipotropin. Also provided are pharmaceutical compositions comprising beta-lipotropin or fragments and/or analogs thereof, and methods for treating diabetes and complications associated therewith by administration of an effective amount of beta-lipotropin.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: November 27, 2001
    Assignee: Eli Lilly and Company
    Inventors: John Edward Hale, Mark Louis Heiman, Brigitte Elisabeth Schoner, William Francis Heath, Jr.
  • Patent number: 5723456
    Abstract: A method for treating endothelial cell dysfunction, such as associated with cardiovascular disease are disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-?N,N'-1,1'-((27"-ethoxy)-3'"(O)-4'"-(N,N-dimethylamino)-butane)-bi s-(3,3'-indolyl)!-1(H)-pyrrole-2,5-dione hydrochloride salt.
    Type: Grant
    Filed: June 13, 1996
    Date of Patent: March 3, 1998
    Assignee: Eli Lilly & Company
    Inventors: Michael R. Jirousek, William Francis Heath, Jr., Douglas Kirk Ways, Lawrence E. Stramm